Thin Film Drugs Market size is expected to grow at a CAGR of 11.10% throughout the forecast period, reaching nearly US$ 18.07 Bn . by 2029. Thin film drugs have emerged as an alternative to tablets or capsules due to its effective therapeutic results. The drugs are made of polymers that rapidly dissolve when kept in the mouth or buccal cavity, delivering the drug directly to systemic circulation in the body. Increasing demand for effective drug delivery systems, coupled with increasing research to develop newer polymeric thin films are expected to increase the demand for thin film drugs. The low manufacturing cost of thin film drugs as compared to traditional dosage forms has proven to be integral market driver in the global market. However, high costs associated with the treatment is restraining the market growth.Effective therapeutic output of the drugs when compared to traditional drugs provides a lucrative opportunity for the market to grow.To know about the Research Methodology :- Request Free Sample Report The thin film drugs market is segmented based on product, disease indication, and region. By product, the market is divided into oral thin films, transdermal thin films, and others. Oral thin film segment is expected to exhibit highest market share at a CAGR of xx% over forecast period. By geography, global thin film drugs market is segmented into North America, APAC, Europe, MEA& Africa and Latin America. North America is expected to exhibit highest market share at a CAGR of xx% over forecast period. As of 2018, North America thin film drug manufacturing market accounted for a share of more than 65% thanks to the structured pharmaceutical industry in the region. Key players operating in this market are MonoSol Rx, Tesa Labtec GmbH, Pfizer, Inc., Novartis AG, and Wolters Kluwer, Solvay, Allergan plc. Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp, and Transition Therapeutics, Inc. are provided in this report. These key players are adopting various organic and inorganic growth strategies to enhance their business operations and regional presence. The objective of the report is to present comprehensive analysis of Thin Film Drugs Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding thin film drugs market dynamics, structure by analysing the market segments, and project the global critical communication market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Thin Film Drugs Market make the report investor’s guide.
Thin Film Drugs Market Scope: Inquire before buying
Global Thin Film Drugs Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US$ 8.64 Bn . Forecast Period 2023 to 2029 CAGR: 11.10% Market Size in 2029: US$ 18.07 Bn. Segments Covered: by Product Oral Thin Film Transdermal Thin Film Others by Disease Indication Schizophrenia Migraine Opioid Dependence Nausea & Vomiting Others Thin Film Drugs Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Thin Film Drugs Market Key Players are:
1.MonoSol Rx 2.Tesa Labtec GmbH 3.Pfizer, Inc. 4.Novartis AG 5.Wolters Kluwer 6.Solvay 7.Allergan plc. 8.Sumitomo Dainippon Pharma Co., Ltd. 9.IntelGenx Corp 10.Transition Therapeutics, Inc. 11.Allergan plc. 12.ZIM Laboratories Limited 13.Indivior plc 14.Sanofi 15.Church & Dwight 16.Tapemark Frequently Asked Questions: 1. Which region has the largest share in Global Thin Film Drugs Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Thin Film Drugs Market? Ans: The Global market is expected to growing at a CAGR of 11.10% during forecast period 2023-2029. 3. What is scope of the Global Thin Film Drugs market report? Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Thin Film Drugs market? Ans: The important key players in the Global market are , MonoSol Rx, Tesa Labtec GmbH, Pfizer, Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc., Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp, Transition Therapeutics, Inc., Allergan plc., ZIM Laboratories Limited, Indivior plc, Sanofi, Church & Dwight, and Tapemark. 5. What is the study period of this market? Ans: The Global market is studied from 2022 to 2029.
Global Thin Film Drugs Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Thin Film Drugs Market, by Market Value (US$ Bn) and Volume(Ton) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Thin Film Drugs Market Analysis and Forecast 6.1. Global Thin Film Drugs Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Thin Film Drugs Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Thin Film Drugs Market Value Share Analysis, by Product 7.4. Global Thin Film Drugs Market Size (US$ Bn) Forecast, by Product 7.5. Global Thin Film Drugs Market Analysis, by Product 7.6. Global Thin Film Drugs Market Attractiveness Analysis, by Product 8. Global Thin Film Drugs Market Analysis and Forecast, by Disease Indication 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Thin Film Drugs Market Value Share Analysis, by Disease Indication 8.4. Global Thin Film Drugs Market Size (US$ Bn) Forecast, by Disease Indication 8.5. Global Thin Film Drugs Market Analysis, by Disease Indication 8.6. Global Thin Film Drugs Market Attractiveness Analysis, by Disease Indication 9. Global Thin Film Drugs Market Analysis, by Region 9.1. Global Thin Film Drugs Market Value Share Analysis, by Region 9.2. Global Thin Film Drugs Market Size (US$ Bn) Forecast, by Region 9.3. Global Thin Film Drugs Market Attractiveness Analysis, by Region 10. North America Thin Film Drugs Market Analysis 10.1. Key Findings 10.2. North America Thin Film Drugs Market Overview 10.3. North America Thin Film Drugs Market Value Share Analysis, by Product 10.4. North America Thin Film Drugs Market Forecast, by Product 10.4.1. Oral Thin Film 10.4.2. Transdermal Thin Film 10.4.3. Others 10.5. North America Thin Film Drugs Market Value Share Analysis, by Disease Indication 10.6. North America Thin Film Drugs Market Forecast, by Disease Indication 10.6.1. Schizophrenia 10.6.2. Migraine 10.6.3. Opioid Dependence 10.6.4. Nausea & Vomiting 10.6.5. Others 10.7. North America Thin Film Drugs Market Value Share Analysis, by Country 10.8. North America Thin Film Drugs Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Thin Film Drugs Market Analysis, by Country 10.10. U.S. Thin Film Drugs Market Forecast, by Product 10.10.1. Oral Thin Film 10.10.2. Transdermal Thin Film 10.10.3. Others 10.11. U.S. Thin Film Drugs Market Forecast, by Disease Indication 10.11.1. Schizophrenia 10.11.2. Migraine 10.11.3. Opioid Dependence 10.11.4. Nausea & Vomiting 10.11.5. Others 10.12. Canada Thin Film Drugs Market Forecast, by Product 10.12.1. Oral Thin Film 10.12.2. Transdermal Thin Film 10.12.3. Others 10.13. Canada Thin Film Drugs Market Forecast, by Disease Indication 10.13.1. Schizophrenia 10.13.2. Migraine 10.13.3. Opioid Dependence 10.13.4. Nausea & Vomiting 10.13.5. Others 10.14. North America Thin Film Drugs Market Attractiveness Analysis 10.14.1. By Product 10.14.2. By Disease Indication 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Thin Film Drugs Market Analysis 11.1. Key Findings 11.2. Europe Thin Film Drugs Market Overview 11.3. Europe Thin Film Drugs Market Value Share Analysis, by Product 11.4. Europe Thin Film Drugs Market Forecast, by Product 11.4.1. Oral Thin Film 11.4.2. Transdermal Thin Film 11.4.3. Others 11.5. Europe Thin Film Drugs Market Value Share Analysis, by Disease Indication 11.6. Europe Thin Film Drugs Market Forecast, by Disease Indication 11.6.1. IoT 11.6.2. AI & Analytics 11.6.3. Digital Twin 11.6.4. Cloud Computing Security 11.6.5. Blockchain 11.7. Europe Thin Film Drugs Market Value Share Analysis, by Country 11.8. Europe Thin Film Drugs Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Thin Film Drugs Market Analysis, by Country 11.10. Germany Thin Film Drugs Market Forecast, by Product 11.10.1. Oral Thin Film 11.10.2. Transdermal Thin Film 11.10.3. Others 11.11. Germany Thin Film Drugs Market Forecast, by Disease Indication 11.11.1. Schizophrenia 11.11.2. Migraine 11.11.3. Opioid Dependence 11.11.4. Nausea & Vomiting 11.11.5. Others 11.12. U.K. Thin Film Drugs Market Forecast, by Product 11.12.1. Oral Thin Film 11.12.2. Transdermal Thin Film 11.12.3. Others 11.13. U.K. Thin Film Drugs Market Forecast, by Disease Indication 11.13.1. Schizophrenia 11.13.2. Migraine 11.13.3. Opioid Dependence 11.13.4. Nausea & Vomiting 11.13.5. Others 11.14. France Thin Film Drugs Market Forecast, by Product 11.14.1. Oral Thin Film 11.14.2. Transdermal Thin Film 11.14.3. Others 11.15. France Thin Film Drugs Market Forecast, by Disease Indication 11.15.1. Schizophrenia 11.15.2. Migraine 11.15.3. Opioid Dependence 11.15.4. Nausea & Vomiting 11.15.5. Others 11.16. Italy Thin Film Drugs Market Forecast, by Product 11.16.1. Oral Thin Film 11.16.2. Transdermal Thin Film 11.16.3. Others 11.17. Italy Thin Film Drugs Market Forecast, by Disease Indication 11.17.1. Schizophrenia 11.17.2. Migraine 11.17.3. Opioid Dependence 11.17.4. Nausea & Vomiting 11.17.5. Others 11.18. Spain Thin Film Drugs Market Forecast, by Product 11.18.1. Oral Thin Film 11.18.2. Transdermal Thin Film 11.18.3. Others 11.19. Spain Thin Film Drugs Market Forecast, by Disease Indication 11.19.1. Schizophrenia 11.19.2. Migraine 11.19.3. Opioid Dependence 11.19.4. Nausea & Vomiting 11.19.5. Others 11.20. Rest of Europe Thin Film Drugs Market Forecast, by Product 11.20.1. Oral Thin Film 11.20.2. Transdermal Thin Film 11.20.3. Others 11.21. Rest of Europe Thin Film Drugs Market Forecast, by Disease Indication 11.21.1. Schizophrenia 11.21.2. Migraine 11.21.3. Opioid Dependence 11.21.4. Nausea & Vomiting 11.21.5. Others 11.22. Europe Thin Film Drugs Market Attractiveness Analysis 11.22.1. By Product 11.22.2. By Disease Indication 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Development 12. Asia Pacific Thin Film Drugs Market Analysis 12.1. Key Findings 12.2. Asia Pacific Thin Film Drugs Market Overview 12.3. Asia Pacific Thin Film Drugs Market Value Share Analysis, by Product 12.4. Asia Pacific Thin Film Drugs Market Forecast, by Product 12.4.1. Oral Thin Film 12.4.2. Transdermal Thin Film 12.4.3. Others 12.5. Asia Pacific Thin Film Drugs Market Value Share Analysis, by Disease Indication 12.6. Asia Pacific Thin Film Drugs Market Forecast, by Disease Indication 12.6.1. Schizophrenia 12.6.2. Migraine 12.6.3. Opioid Dependence 12.6.4. Nausea & Vomiting 12.6.5. Others 12.7. Asia Pacific Thin Film Drugs Market Value Share Analysis, by Country 12.8. Asia Pacific Thin Film Drugs Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Thin Film Drugs Market Analysis, by Country 12.10. China Thin Film Drugs Market Forecast, by Product 12.10.1. Oral Thin Film 12.10.2. Transdermal Thin Film 12.10.3. Others 12.11. China Thin Film Drugs Market Forecast, by Disease Indication 12.11.1. Schizophrenia 12.11.2. Migraine 12.11.3. Opioid Dependence 12.11.4. Nausea & Vomiting 12.11.5. Others 12.12. India Thin Film Drugs Market Forecast, by Product 12.12.1. Oral Thin Film 12.12.2. Transdermal Thin Film 12.12.3. Others 12.13. India Thin Film Drugs Market Forecast, by Disease Indication 12.13.1. Schizophrenia 12.13.2. Migraine 12.13.3. Opioid Dependence 12.13.4. Nausea & Vomiting 12.13.5. Others 12.14. Japan Thin Film Drugs Market Forecast, by Product 12.14.1. Oral Thin Film 12.14.2. Transdermal Thin Film 12.14.3. Others 12.15. Japan Thin Film Drugs Market Forecast, by Disease Indication 12.15.1. Schizophrenia 12.15.2. Migraine 12.15.3. Opioid Dependence 12.15.4. Nausea & Vomiting 12.15.5. Others 12.16. ASEAN Thin Film Drugs Market Forecast, by Product 12.16.1. Oral Thin Film 12.16.2. Transdermal Thin Film 12.16.3. Others 12.17. ASEAN Thin Film Drugs Market Forecast, by Disease Indication 12.17.1. Schizophrenia 12.17.2. Migraine 12.17.3. Opioid Dependence 12.17.4. Nausea & Vomiting 12.17.5. Others 12.18. Rest of Asia Pacific Thin Film Drugs Market Forecast, by Product 12.18.1. Oral Thin Film 12.18.2. Transdermal Thin Film 12.18.3. Others 12.19. Rest of Asia Pacific Thin Film Drugs Market Forecast, by Disease Indication 12.19.1. Schizophrenia 12.19.2. Migraine 12.19.3. Opioid Dependence 12.19.4. Nausea & Vomiting 12.19.5. Others 12.20. Asia Pacific Thin Film Drugs Market Attractiveness Analysis 12.20.1. By Product 12.20.2. By Disease Indication 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Development 13. Middle East & Africa Thin Film Drugs Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Thin Film Drugs Market Overview 13.3. Middle East & Africa Thin Film Drugs Market Value Share Analysis, by Product 13.4. Middle East & Africa Thin Film Drugs Market Forecast, by Product 13.4.1. Oral Thin Film 13.4.2. Transdermal Thin Film 13.4.3. Others 13.5. Middle East & Africa Thin Film Drugs Market Value Share Analysis, by Disease Indication 13.6. Middle East & Africa Thin Film Drugs Market Forecast, by Disease Indication 13.6.1. Schizophrenia 13.6.2. Migraine 13.6.3. Opioid Dependence 13.6.4. Nausea & Vomiting 13.6.5. Others 13.7. Middle East & Africa Thin Film Drugs Market Value Share Analysis, by Country 13.8. Middle East & Africa Thin Film Drugs Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Thin Film Drugs Market Analysis, by Country 13.10. GCC Thin Film Drugs Market Forecast, by Product 13.10.1. Oral Thin Film 13.10.2. Transdermal Thin Film 13.10.3. Others 13.11. GCC Thin Film Drugs Market Forecast, by Disease Indication 13.11.1. Schizophrenia 13.11.2. Migraine 13.11.3. Opioid Dependence 13.11.4. Nausea & Vomiting 13.11.5. Others 13.12. South Africa Thin Film Drugs Market Forecast, by Product 13.12.1. Oral Thin Film 13.12.2. Transdermal Thin Film 13.12.3. Others 13.13. South Africa Thin Film Drugs Market Forecast, by Disease Indication 13.13.1. Schizophrenia 13.13.2. Migraine 13.13.3. Opioid Dependence 13.13.4. Nausea & Vomiting 13.13.5. Others 13.14. Rest of Middle East & Africa Thin Film Drugs Market Forecast, by Product 13.14.1. Oral Thin Film 13.14.2. Transdermal Thin Film 13.14.3. Others 13.15. Rest of Middle East & Africa Thin Film Drugs Market Forecast, by Disease Indication 13.15.1. Schizophrenia 13.15.2. Migraine 13.15.3. Opioid Dependence 13.15.4. Nausea & Vomiting 13.15.5. Others 13.16. Middle East & Africa Thin Film Drugs Market Attractiveness Analysis 13.16.1. By Product 13.16.2. By Disease Indication 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Development 14. South America Thin Film Drugs Market Analysis 14.1. Key Findings 14.2. South America Thin Film Drugs Market Overview 14.3. South America Thin Film Drugs Market Value Share Analysis, by Product 14.4. South America Thin Film Drugs Market Forecast, by Product 14.4.1. Oral Thin Film 14.4.2. Transdermal Thin Film 14.4.3. Others 14.5. South America Thin Film Drugs Market Value Share Analysis, by Disease Indication 14.6. South America Thin Film Drugs Market Forecast, by Disease Indication 14.6.1. Schizophrenia 14.6.2. Migraine 14.6.3. Opioid Dependence 14.6.4. Nausea & Vomiting 14.6.5. Others 14.7. South America Thin Film Drugs Market Value Share Analysis, by Country 14.8. South America Thin Film Drugs Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Thin Film Drugs Market Analysis, by Country 14.10. Brazil Thin Film Drugs Market Forecast, by Product 14.10.1. Oral Thin Film 14.10.2. Transdermal Thin Film 14.10.3. Others 14.11. Brazil Thin Film Drugs Market Forecast, by Disease Indication 14.11.1. Schizophrenia 14.11.2. Migraine 14.11.3. Opioid Dependence 14.11.4. Nausea & Vomiting 14.11.5. Others 14.12. Mexico Thin Film Drugs Market Forecast, by Product 14.12.1. Oral Thin Film 14.12.2. Transdermal Thin Film 14.12.3. Others 14.13. Mexico Thin Film Drugs Market Forecast, by Disease Indication 14.13.1. Schizophrenia 14.13.2. Migraine 14.13.3. Opioid Dependence 14.13.4. Nausea & Vomiting 14.13.5. Others 14.14. Rest of South America Thin Film Drugs Market Forecast, by Product 14.14.1. Oral Thin Film 14.14.2. Transdermal Thin Film 14.14.3. Others 14.15. Rest of South America Thin Film Drugs Market Forecast, by Disease Indication 14.15.1. Schizophrenia 14.15.2. Migraine 14.15.3. Opioid Dependence 14.15.4. Nausea & Vomiting 14.15.5. Others 14.16. South America Thin Film Drugs Market Attractiveness Analysis 14.16.1. By Product 14.16.2. By Disease Indication 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. MonoSol Rx 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. Tesa Labtec GmbH 15.3.3. Pfizer, Inc. 15.3.4. Novartis AG 15.3.5. Wolters Kluwer 15.3.6. Solvay 15.3.7. Allergan plc. 15.3.8. Sumitomo Dainippon Pharma Co., Ltd. 15.3.9. IntelGenx Corp 15.3.10. Transition Therapeutics, Inc. 15.3.11. Allergan plc. 15.3.12. ZIM Laboratories Limited 15.3.13. Indivior plc 15.3.14. Sanofi 15.3.15. Church & Dwight 15.3.16. Tapemark 16. Primary Key Insights